ISG15 and cutaneous melanoma: ISG15 expression is significantly associated with different pathological stages in several cancers, including KIRC, PAAD (pancreatic adenocarcinoma), and SKCM (skin cutaneous melanoma), suggesting a potential role of ISG15 expression levels in dictating pathological progression.